Suchergebnis | Hamburg Open Science

Facetten

25 Einträge gefunden

Health-insurance status is a determinant of the stage at presentation and of cancer control in European men treated with radical prostatectomy for clinically localized prostate cancer.
2007 - Forschungsinformationssystem des UKE
Systematic assessment of the ability of the number and percentage of positive biopsy cores to predict pathologic stage and biochemical recurrence after radical prostatectomy.
2007 - Forschungsinformationssystem des UKE
Development and external validation of an extended repeat biopsy nomogram.
2007 - Forschungsinformationssystem des UKE
Therapy of recurrent disease after radical prostatectomy in 2007.
2007 - Forschungsinformationssystem des UKE
Initial biopsy outcome prediction--head-to-head comparison of a logistic regression-based nomogram versus artificial neural network.
2007 - Forschungsinformationssystem des UKE
Development and split-sample validation of a nomogram predicting the probability of seminal vesicle invasion at radical prostatectomy.
2007 - Forschungsinformationssystem des UKE
Zonal origin of localized prostate cancer does not affect the rate of biochemical recurrence after radical prostatectomy.
2007 - Forschungsinformationssystem des UKE
Is the open retropubic radical prostatectomy dead?
1. Graefen, Markus
2007 - Forschungsinformationssystem des UKE
Management of erectile dysfunction after radical prostatectomy in 2007.
2007 - Forschungsinformationssystem des UKE
Obesity does not predispose to more aggressive prostate cancer either at biopsy or radical prostatectomy in European men.
2007 - Forschungsinformationssystem des UKE
Body mass index does not improve the ability to predict biochemical recurrence after radical prostatectomy.
2007 - Forschungsinformationssystem des UKE
Experiences with a new high-dose-rate brachytherapy (HDR-BT) boost technique for T3b prostate cancer
2007 - Forschungsinformationssystem des UKE
Prediction of pathological stage is inaccurate in men with PSA values above 20 ng/mL.
2007 - Forschungsinformationssystem des UKE
[Technical aspects of nerve sparing during retropubic prostatectomy]
2007 - Forschungsinformationssystem des UKE
Clinical significance of epidermal growth factor receptor protein overexpression and gene copy number gains in prostate cancer.
2007 - Forschungsinformationssystem des UKE
Assay-specific artificial neural networks for five different PSA assays and populations with PSA 2-10 ng/ml in 4,480 men.
2007 - Forschungsinformationssystem des UKE
Percentage of positive biopsy cores can improve the ability to predict lymph node invasion in patients undergoing radical prostatectomy and extended pelvic lymph node dissection.
2007 - Forschungsinformationssystem des UKE
Nerve distribution along the prostatic capsule.
2007 - Forschungsinformationssystem des UKE
A nomogram predicting 10-year life expectancy in candidates for radical prostatectomy or radiotherapy for prostate cancer.
2007 - Forschungsinformationssystem des UKE
Development and external validation of an extended 10-core biopsy nomogram.
2007 - Forschungsinformationssystem des UKE

Aktive Facetten

Facetten

Zugriff

Einrichtung

Medientyp

Karte

Erscheinungsjahr

Autor/in

Sprache

Health-insurance status is a determinant of the stage at presentation and of cancer control in European men treated with radical prostatectomy for clinically localized prostate cancer.

Systematic assessment of the ability of the number and percentage of positive biopsy cores to predict pathologic stage and biochemical recurrence after radical prostatectomy.

Development and external validation of an extended repeat biopsy nomogram.

Therapy of recurrent disease after radical prostatectomy in 2007.

Initial biopsy outcome prediction--head-to-head comparison of a logistic regression-based nomogram versus artificial neural network.

Development and split-sample validation of a nomogram predicting the probability of seminal vesicle invasion at radical prostatectomy.

Zonal origin of localized prostate cancer does not affect the rate of biochemical recurrence after radical prostatectomy.

Is the open retropubic radical prostatectomy dead?

Management of erectile dysfunction after radical prostatectomy in 2007.

Obesity does not predispose to more aggressive prostate cancer either at biopsy or radical prostatectomy in European men.

Body mass index does not improve the ability to predict biochemical recurrence after radical prostatectomy.

Experiences with a new high-dose-rate brachytherapy (HDR-BT) boost technique for T3b prostate cancer

Prediction of pathological stage is inaccurate in men with PSA values above 20 ng/mL.

[Technical aspects of nerve sparing during retropubic prostatectomy]

Clinical significance of epidermal growth factor receptor protein overexpression and gene copy number gains in prostate cancer.

Assay-specific artificial neural networks for five different PSA assays and populations with PSA 2-10 ng/ml in 4,480 men.

Percentage of positive biopsy cores can improve the ability to predict lymph node invasion in patients undergoing radical prostatectomy and extended pelvic lymph node dissection.

Nerve distribution along the prostatic capsule.

A nomogram predicting 10-year life expectancy in candidates for radical prostatectomy or radiotherapy for prostate cancer.

Development and external validation of an extended 10-core biopsy nomogram.